Cargando…
Small non-coding RNA therapeutics for cardiovascular disease
Novel bio-therapeutic agents that harness the properties of small, non-coding nucleic acids hold great promise for clinical applications. These include antisense oligonucleotides that inhibit messenger RNAs, microRNAs (miRNAs), or long non-coding RNAs; positive effectors of the miRNA pathway (short...
Autores principales: | Shah, Ajay M, Giacca, Mauro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659475/ https://www.ncbi.nlm.nih.gov/pubmed/36106499 http://dx.doi.org/10.1093/eurheartj/ehac463 |
Ejemplares similares
-
Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options
por: Jankowski, Joachim, et al.
Publicado: (2021) -
Therapeutic and Diagnostic Translation of Extracellular Vesicles in Cardiovascular Diseases: Roadmap to the Clinic
por: Sahoo, Susmita, et al.
Publicado: (2021) -
Therapeutic Genome Editing in Cardiovascular Diseases
por: German, David M., et al.
Publicado: (2019) -
Strategy of Patient-Specific Therapeutics in Cardiovascular Disease Through Single-Cell RNA Sequencing
por: Jung, Yunseo, et al.
Publicado: (2022) -
Inflammation and cardiovascular disease: From mechanisms to therapeutics
por: Alfaddagh, Abdulhamied, et al.
Publicado: (2020)